User:Faithhsu13/Decolonization (medicine)
 | This is the sandbox page where you will draft your initial Wikipedia contribution.
If you're starting a new article, you can develop it here until it's ready to go live. If you're working on improvements to an existing article, copy only one section at a time of the article to this sandbox to work on, and be sure to use an edit summary linking to the article you copied from. Do not copy over the entire article. You can find additional instructions here. Remember to save your work regularly using the "Publish page" button. (It just means 'save'; it will still be in the sandbox.) You can add bold formatting to your additions to differentiate them from existing content. |
Decolonization (medicine)
[edit]Decolonization, also bacterial decolonization, is a medical intervention that attempts to rid a patient of an antimicrobial resistant pathogen, such as methicillin-resistant Staphylococcus aureus (MRSA) or antifungal-resistant Candida.
By preemptively treating patients who have become colonized with an antimicrobial resistant organism, the likelihood of the patient going on to develop life-threatening health care-associated infections is reduced. Common sites of bacterial colonization include the nasal passage, groin, oral cavity and skin.
History
[edit]In cooperation with the Centers for Disease Control and Prevention (CDC), the Chicago Antimicrobial Resistance and Infection Prevention Epicenter (C-PIE), Harvard/Irvine Bi-Coastal Epicenter, and Washington University and Barnes Jewish County (BJC) Center for Prevention of Healthcare-Associated Infections conducted a study to test different strategies to prevent and decrease the rate of healthcare-associated infections (HAIs).[1] This study was named REDUCE MRSA, which stands for Randomized Evaluation of Decolonization vs. Universal Clearance to Eliminate methicillin-resistant Staphylococcus aureus (MRSA), and was completed over an 18-month period from January 2009 to September 2011.[2] This study determined decolonization with chlorhexidine and mupirocin of all patients without screening was the most effective at reducing the presence of MRSA and overall number of bloodstream infections.[2]
Medical Uses
[edit]Decolonization is used to reduce rates of infections caused by MRSA. Staphylococcus aureus (S. aureus) is a common cause of hospital related infections, including blood stream infections and infections of the heart and bone.[3] Additionally, increasing cases of methicillin-susceptible S. aureus (MSSA) and MRSA pose a new challenge as these strains are difficult or impossible to treat with standard antibiotic regimens. S. aureus is commonly found in many areas of the body like the nose and throat. Because of the prevalence of S. aureus within the general population and significant number of severe infections caused by this bacteria, decolonization protocols have been implemented in many hospital networks to decrease MRSA infections.[2] By using disinfectants over an extended period of time, decolonization decreases or minimizes patient bacterial load.
Technique
[edit]There are several decolonization regimens currently used for MRSA decolonization. Targeted decolonization involves screening patients for MRSA then isolating and implementing decolonization protocols only for patients who test positive for MRSA. On the other hand, universal decolonization involves no screening and decolonization for all patients in a given hospital setting or department.[4]
Products used for decolonization typically involve chlorhexidine rinses for bathing or showering, a mouthwash to clean the oral cavity, and a nasal spray containing mupirocin. It is important to include a mouthwash and nasal spray as individuals commonly carry MRSA in the nose, mouth, and throat. Chlorhexidine is a disinfectant that is used to disinfect skin prior to surgery, surgical instrument sterilization, and in hand disinfectants in healthcare settings. In the mouthwash form, it is commonly used for gingivitis.[5] Mupirocin is a topical antibiotic commonly used for superficial skin infections and has been approved by the FDA nasal decolonization.[6][7] Though these are the most commonly used products, there are a number of alternative antibiotics and antiseptics, like povidone-iodine, that are used in decolonization.
Typically, patients use chlorhexidine shampoo or body wash daily and mupirocin nasal spray twice daily. The duration of product use for optimal effect is still being studied, but the most widely studied regimen recommends use of the products as mentioned previously for five days twice a month over a sixth month period.[2] There is limited data supporting decolonization or recommendations of duration of decolonization in outpatient settings.[8]
Risks and Complications
[edit]Decolonization is a relatively safe medical intervention. Local skin irritation is the most common side effect.[2]
References
[edit]- ^ "REDUCE MRSA | HAI Prevention Epicenters Program | CDC". www.cdc.gov. 2019-02-13. Retrieved 2022-09-16.
- ^ a b c d e Huang, S.S.; Singh, R.; McKinnell, J.A.; Park, S.; Gombosev, A.; Eells, S.J.; Gillen, D.L.; Kim, D.; Rashid, S.; Macias-Gil, R.; Bolaris, M.A.; Tjoa, T.; Cao, C.; Hong, S.S.; Lequieu, J. (2019-02-14). "Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers". The New England journal of medicine. 380 (7): 638–650. doi:10.1056/NEJMoa1716771. ISSN 0028-4793. PMC 6475519. PMID 30763195.
- ^ Lepelletier, Didier; Maillard, Jean Yves; Pozzetto, Bruno; Simon, Anne (2020-08-20). "Povidone Iodine: Properties, Mechanisms of Action, and Role in Infection Control and Staphylococcus aureus Decolonization". Antimicrobial Agents and Chemotherapy. 64 (9): e00682–20. doi:10.1128/AAC.00682-20. ISSN 0066-4804. PMC 7449185. PMID 32571829.
- ^ "REDUCE MRSA | HAI Prevention Epicenters Program | CDC". www.cdc.gov. 2019-02-13. Retrieved 2022-09-16.
- ^ "Chlorhexidine (Topical Application Route) Description and Brand Names - Mayo Clinic". www.mayoclinic.org. Retrieved 2022-09-16.
- ^ "Mupirocin Monograph for Professionals". Drugs.com. Retrieved 2022-09-16.
- ^ Mehta, Sapna; Hadley, Scott; Hutzler, Lorraine; Slover, James; Phillips, Michael; Bosco, Joseph A. (2013-7). "Impact of Preoperative MRSA Screening and Decolonization on Hospital-acquired MRSA Burden". Clinical Orthopaedics and Related Research. 471 (7): 2367–2371. doi:10.1007/s11999-013-2848-3. ISSN 0009-921X. PMC 3676612. PMID 23423618.
{{cite journal}}: Check date values in:|date=(help) - ^ Simor, Andrew E.; Phillips, Elizabeth; McGeer, Allison; Konvalinka, Ana; Loeb, Mark; Devlin, H. Rosalyn; Kiss, Alex (2007-01-15). "Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 44 (2): 178–185. doi:10.1086/510392. ISSN 1537-6591. PMID 17173213.